Circulating MicroRNA as Thrombosis Sentinels: Caveats and Considerations

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Small noncoding RNAs, microRNAs (miRNAs), are increasingly recognized for their disease diagnostic potential.
• While implicated in various diseases, their specific roles in hemostasis and coagulation are less understood.
• Circulating miRNA measurement and platelet activation present challenges in studying thrombosis-associated miRNAs.

Purpose of the Study:

• To review current knowledge on miRNAs regulating hemostatic factors.
• To discuss miRNA diagnostic panels for thrombotic diseases.
• To highlight experimental considerations for accurate miRNA biomarker evaluation.

Main Methods:

• Literature review of studies on miRNAs in hemostasis and thrombosis.
• Analysis of experimental challenges in circulating miRNA measurement.
• Focus on condition-specific reference controls for miRNA evaluation.

Main Results:

• miRNAs are postulated to regulate key hemostatic factors.
• miRNA panels show potential for diagnosing thrombotic diseases.
• Accurate evaluation requires careful selection of reference controls and consideration of platelet activation.

Conclusions:

• miRNAs are significant regulators in hemostasis and coagulation.
• Addressing measurement complexities is crucial for developing reliable miRNA biomarkers for thrombosis.
• Standardized experimental approaches are needed for clinical application.